HCAT — HEALTH CATALYST INC

Ownership history in Numerai GP LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Numerai GP LLC reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.34% (2022 Q4)
Avg. % of fund
0.87%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 123,241 +70,869 +135.3% 0.05% $351K $2.85
2023 Q1 REDUCED 52,372 -270,534 -83.8% 0.20% $611K $11.67
2022 Q4 INITIATED 322,906 — — 2.34% $3.4M —
% of Fund (quarterly)    HCAT price (monthly, adj. close)

Other funds also holding HCAT

As of 2025 Q4 — sorted by position size

Whetstone Capital Advisors, LLC 3Y 7Y 2.8% First Light Asset Management, LLC 3Y 7Y 2.36% Nepsis Inc. 3Y 7Y 1.41% Palogic Value Management, L.P. 3Y 1.27% HighMark Wealth Management LLC 3Y 0.72% MARTIN & CO INC /TN/ 3Y 7Y 0.21% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.07% CVS HEALTH Corp 3Y 0.06% nVerses Capital, LLC 0.06% Williams & Novak, LLC 0.05%
← Back to Numerai GP LLC Holdings